WebOct 31, 2024 · This time, SciGen is recalling certain lots of irbesartan. The recalled lot will have “Westminster Pharmaceuticals” and “GSMS Inc.” on the label, according to the FDA list. WebThe October 2024 recall affects multiple batches of the drug, supplied by Aurobindo Pharam Limited, headquartered in India. The recalled ScieGen Pharmaceuticals Inc. Irbesartan …
Irbesartan Information, Side Effects, Warnings and Recalls - Recall …
Web• On October 12, 2024, Lupin announced a consumer level recall of 15 lots of irbesartan tablets and 32 lots of irbesartan/HCTZ tablets because certain active pharmaceutical … WebOct 20, 2024 · October 20, 2024 - Lupin Pharmaceuticals Inc. is voluntarily recalling certain lots of Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets to the consumer level. As part of Lupin’s ongoing assessment, analysis revealed that certain tested batches (but not finished product batches) were above the specification limit for the impurity, N … pop out homes
Blood pressure medicine recall from FDA: Call your doctor now
WebOct 20, 2024 · The company recalled all batches of its Irbesartan tablets (75 mg, 150 mg and 300 mg) and Irbesartan-Hydrochlorothiazide (150 mg/12.5 mg and 300 mg/12.5 mg). … WebSep 27, 2024 · Currently, the recall affects only medications containing valsartan, losartan, or irbesartan. However, not all lots of these medications are affected and being recalled. WebMar 7, 2024 · “ScieGen Pharmaceuticals, Inc. is voluntarily recalling listed lots, within expiry, of Irbesartan Tablets, USP 75 mg, 150 mg, and 300 mg dosage forms to the consumer level. These products are being recalled due to the presence of an impurity, N-nitrosodiethylamine (NDEA) contained in the API [active pharmaceutical ingredient] Irbesartan, USP ... pop out hinge